Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults
Abstract Fifteen years after its licensure, this revision assesses the role of cefditoren facing the current pharmacoepidemiology of resistances in respiratory human-adapted pathogens (Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis). In the era of...
Main Authors: | María-José Giménez, Lorenzo Aguilar, Juan José Granizo |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Mattioli 1885
2018-11-01
|
Colecção: | Multidisciplinary Respiratory Medicine |
Acesso em linha: | http://link.springer.com/article/10.1186/s40248-018-0152-5 |
Registos relacionados
-
Cefditoren in upper and lower community-acquired respiratory tract infections
Por: Francisco Soriano, et al.
Publicado em: (2011-02-01) -
CEFDITOREN IN THE TREATMENT OF PURULENT RINOSINUSITIS
Por: G. N. Nikiforova, et al.
Publicado em: (2017-11-01) -
Update on the clinical utility and optimal use of cefditoren
Por: Barberán J, et al.
Publicado em: (2012-05-01) -
ANTIBACTERIAL THERAPY OF ACUTE RINOSINUSITIS BY CEFDITOREN
Por: S. V. Ryazantsev, et al.
Publicado em: (2017-05-01) -
High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.
Por: David Sevillano, et al.
Publicado em: (2008-01-01)